Adaptimmune Therapeutics Plc Preço/Vendas
Qual é o Preço/Vendas de Adaptimmune Therapeutics Plc?
O Preço/Vendas de Adaptimmune Therapeutics Plc é 1.60
Qual é a definição de Preço/Vendas?
A razão entre preço e vendas é o preço das ações de uma empresa em comparação com as suas receitas.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Preço/Vendas de empresas na Setor Health Care em NASDAQ em comparação com Adaptimmune Therapeutics Plc
O que Adaptimmune Therapeutics Plc faz?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Empresas com preço/vendas semelhantes a Adaptimmune Therapeutics Plc
- Mahindra EPC Irrigation tem Preço/Vendas de 1.60
- Virtus Investment Partners Inc tem Preço/Vendas de 1.60
- Aditya Birla Money tem Preço/Vendas de 1.60
- Tinybeans tem Preço/Vendas de 1.60
- TCI Finance tem Preço/Vendas de 1.60
- Dish TV India tem Preço/Vendas de 1.60
- Adaptimmune Therapeutics Plc tem Preço/Vendas de 1.60
- Eumundi tem Preço/Vendas de 1.60
- Tristel tem Preço/Vendas de 1.60
- Royal Catering tem Preço/Vendas de 1.60
- Zoom Telephonics tem Preço/Vendas de 1.60
- Sabre Insurance Plc tem Preço/Vendas de 1.60
- Matachewan Consolidated Mines tem Preço/Vendas de 1.60